Differences in tumour growth, tumour cell proliferation and immune function after laparoscopy and laparotomy in an animal model  by Lopes, A.G. et al.
213
Introduction
The association between postoperative morbidity and the
magnitude of surgical operations has long been recognised,
Lord Moynihan noted that ‘the cleaner and gentler the act
of operation, the better to the patient’ [1]. In 1985 Lennard
and colleagues established a scientific basis for this clinical
observation by demonstrating that cellular immunity was
disturbed for up to 7 days after major operations and that
the greater the surgical stress, the weaker the immune
response [2].
The introduction of laparoscopy into the field of gen-
eral surgery in 1987 [3] has changed the speciality, and
since then several studies have been performed to compare
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Background
Clinical and experimental studies have shown that
laparoscopy preserves the immune response and can give
better clinical results than laparotomy. However, the use of
laparoscopy for the treatment of cancer patients is still
controversial due to the risk of port-site and haematoge-
nous metastases and increased tumour growth. The pur-
pose of this experimental study was to assess tumour
growth and the mechanism of differential tumour behav-
iour after laparoscopy and laparotomy.
Methods
Seventy-five young, male Wistar rats were randomly
assigned to one of two experiments. Experiment 1: 45 ani-
mals were inoculated subcutaneously with Walker carci-
nosarcoma 256 cells and were subdivided into three
groups of 15 rats. Control group 1a was submitted to
anaesthesia only, group 1b received carbon dioxide (CO
2
)
pneumoperitoneum, while group 1c received a laparotomy.
Animals were sacrificed on postoperative day (POD) 7;
tumours were excised and weighed to evaluate tumour
growth. Nucleolar organiser regions identified by silver
staining (AgNORs) were analysed to evaluate cell prolifer-
ation. Experiment 2: 30 rats were submitted to the same
procedures as before, with ten animals in each group
(2a, 2b, 2c), and a delayed-type hypersensitivity response
(DTH) was used to evaluate the immune function.
Results
The average tumour mass was 1.76 g in group 1a, 2.81 g in
group 1b and 4.21 g in group 1c (p , 0.05). The AgNOR
expression results were similar in the three groups. The
immune function was better preserved in the control
group (2a: average inflammatory area on POD1 5 106
mm2 and on POD2 5 128.18 mm
2), than in the pneu-
moperitoneum group (2b: average inflammatory area on
POD1 5 79.75 mm
2 and on POD2 5 126.93 mm
2); the
worst results were in the laparotomy group (2c: average
inflammatory area on POD1 5 33.33 mm
2 and on POD2
5 61.32 mm
2).There were significant differences between
groups 2a and 2c and between 2b and 2c.
Conclusion
Laparotomy stimulates a greater tumour growth than CO
2
pneumoperitoneum, but there is no difference in tumour
cell proliferation. The cellular immune function is better
preserved in animals submitted to CO
2
pneumoperi-
toneum than in the laparotomised animals. These results
suggest a relationship between a weaker immune response
and a greater tumour growth.
Keywords
tumour growth, tumour cell proliferation, delayed-type
hypersensitivity, pneumoperitoneum, laparotomy, rat.
Correspondence to: Dr AG Lopes Jr, Liver Transplant Surgical Service,
King’s College Hospital, Denmark Hill, London SE5 9RS, UK (until
December 2001) or Av. Adhemar Pereira de Barros, 387, Londrina -
PR, 86050-160, Brazil (from December 2001)
HPB 2001 Volume 3, Number 3 213–217
© 2001 Martin Dunitz Ltd.
laparoscopic versus open operation. It has been shown that
laparoscopic interventions preserve immune responses
[4–8] and have better clinical results [9,10] than laparo-
tomy. These results stimulated the use of laparoscopy for
the treatment of cancer [11,12]. However, much contro-
versy surrounds the use of this surgical technique for the
treatment of malignant diseases due to the risk of port-site
metastases [13], haematogenous metastases [14,15] and
increased tumour growth [16,17].
Several studies have been carried out to compare
tumour growth in animals submitted to laparoscopy or
laparotomy, with controversial results. In 1995 Allendorf
and co-workers injected mammary carcinoma (MC-2)
intradermally in three groups of mice and submitted the
animals to laparotomy, CO2 pneumoperitoneum and sham
operation (control group) [18]. They demonstrated that the
tumours implanted in the group submitted to laparotomy
grew more than the tumours in the pneumoperitoneum and
control groups. However, Jacobi and associates found oppo-
site results in a similar study, using subcutaneous implanta-
tion of DHD/K12/TRb colon carcinoma in rats [16];
tumour growth was greater in the animals submitted to CO
2
pneumoperitoneum. Furthermore, Moreno and colleagues
found no difference in tumour growth after laparoscopy or
laparotomy [17].
The mechanism for differing tumour behaviour after
open and laparoscopic operation is not clear, but it has
been related to tumour cell proliferation and the immune
function [18,19]. An experimental study has suggested that
there is a higher rate of tumour cell proliferation after
laparotomy than after laparoscopy or sham operation and
that postoperative stimulating factors may be responsible
for this difference [19].
The purposes of the present study were (1) to compare
tumour growth subsequent to laparotomy or abdominal
CO2 insufflation in an animal model and (2) to evaluate
tumour cell proliferation and immune response to clarify
the mechanism of differential tumour behaviour after these
surgical procedures.
Materials and methods
Animals
This study was performed under a protocol approved by the
Research Projects Ethic Committee of the University of
São Paulo Medical School. Seventy-five male Wistar rats,
weighing 170–270 g, were kept under standard laboratory
conditions for no less than 48 h before investigation and
were allowed standard laboratory rodent chow (Nuvilab
CR1) and water ad libitum.
Tumour
An immunogenic tumour [20,21], 256 Walker carcinosar-
coma, obtained from matrices frozen in liquid nitrogen and
10% glycerin solution was thawed, diluted and injected
into the peritoneal cavity of a rat to produce enough viable
tumour cells for the experiments. Between the fifth and
sixth day after inoculation, the animal developed ascites
rich in tumour cells. The ascites was aspirated, and the via-
bility of the tumour cells was verified by the trypan blue
exclusion test. The ascites was diluted to obtain 375 000
tumour cells/ml, and 1 ml was inoculated subcutaneously
on the back of each animal (experiment 1). The number of
cells injected in each animal was chosen in a pilot study so
as to obtain a good tumour growth within 1 week [22].
Challenge antigen
Keyhole limpet haemocyanin (KLH; Sigma Chemical Co.,
St Louis, MO, USA) is a commonly used skin antigen that
requires previous sensitisation of the animal. To generate a
DTH response, the antigen (KLH) must be presented to
and recognised by a specific CD41 lymphocyte (cognitive
phase), which is then stimulated to release cytokine and
proliferate it (activation phase). The release of cytokines
results in wheal formation (effector phase). The inflamma-
tory wheal represents the animal’s cellular immune
response.
Rats were sensitised to KLH via an intramuscular injec-
tion of 1 mg of KLH in 0.2 ml of complete Freund’s adjuvant.
Challenges consisted of intradermal injection of 0.3 mg of
KLH in 0.1 ml of normal saline in the flank of the rats [5].
Operative procedures
Three different operative procedures were performed:
anaesthesia only (control – group a), CO
2
pneumoperi-
toneum (group b) and laparotomy (group c). Anaesthesia
was achieved with inhalation of pure ethyl ether. The
animals were secured to the operating table with adhesive
tape in a supine position. The abdomen was shaved and
povidine-iodine was used for antisepsis. Anaesthesia time
was standardised to 30 min.
The rats undergoing CO
2
pneumoperitoneum had a
5-mm skin incision in the midline of the abdomen two-
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thirds of the way from the xiphoid process towards the sym-
physis pubis. A Verres needle (Ethicon®, model UV120)
was introduced, and 4–6 mmHg CO2 pneumoperitoneum
was achieved for 20 min.
Laparotomised rats underwent a 7-cm midline incision
from the xiphoid process almost to the pubis. The abdomen
remained open for 20 min and the abdominal wall was then
closed with 4/0 mononylon sutures.
Experiment 1
Tumour growth
Forty-five animals were used in this experiment; 375 000
tumour cells were inoculated in the subcutaneous tissue of
each rat, and the animals were then randomly assigned to
one of the three different operative procedures described
previously (Figure 1a). On post operative day (POD) 7, ani-
mals were sacrificed, and tumours were excised and
weighed on a digital Mettler scale (PE 1600). Metastases
were searched for in all animals.
Tumour cell proliferation
All tumours excised were stained for nucleolar organiser
regions (Figure 1a). The argyrophil technique was applied
to 3-µm thick waxed paraffin sections as described previ-
ously [23]. In each case, 200 randomly selected tumour cells
were examined with a 3100 objective, and the number of
nucleolar organiser regions identified by silver staining
(AgNORs) was counted.
Experiment 2
Immune function
A new batch of 30 rats was sensitised to KLH 10 days before
procedures and challenged with KLH 3 days before inter-
ventions to establish the animals’ baseline responses. On
the day of operation all animals were again challenged with
KLH. They were then randomly assigned to one of the
three different operative procedures: anaesthesia only
(group 2a), CO
2
pneumoperitoneum (group 2b) or laparo-
tomy (group 2c) (Figure 1b). Resulting delayed-type hyper-
sensitivity (DTH) wheals were elliptical in shape, and they
were measured 24 and 48 h after each challenge. The
longest diameter (D1) and the diameter of the wheal per-
pendicular to the axis used for the first measurement (D2)
were determined with manual calipers. Induration area was
then calculated by the formula A 5 ( D1/2 x D2/2) 3 p
(area of an ellipse) [5,24].
Statistics
Significant differences among groups were determined by
analysis of variance, followed by the Tukey test, when the
Bartlett test indicated homogeneous variance and the
Shapiro-Wilk test indicated normality of data. When data
were not homogeneous or normal, the Kruskal-Wallis test
was used. Significance was accepted at p,0.05.
Results
Tumour growth
The tumour weight in the control group (1a, mean tumour
weight 1.76 6 0.80 g) was significantly lower than that in
the other groups. The tumour weight in the pneumoperi-
toneum group (1b, mean tumour weight 2.81 6 0.96 g) was
also significantly lower than that in the laparotomy group
(1c, mean tumour weight 4.21 6 0.98 g) (p,0.05) (Figure
2). No metastases were seen in any animal.
Tumour cell proliferation
The mean AgNOR expression in 200 nuclei studied in
each tumour was similar in the three groups of experiment 1.
The value was 232.0 in the control group, 234.6 in the
pneumoperitoneum group and 234.4 in the laparotomy
group (p 5 0.577).
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Figure 1. (a) Tumour growth and tumour cell proliferation: experimental
groups. (b) Immune response: experimental groups.
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Immune function
Preoperative DTH responses to KLH were similar in all
groups of experiment 2 (group 2a, 104.2 mm2; group 2b,
98.64 mm2; group 2c, 98.51 mm2). The first POD response
to KLH was significantly weaker in the laparotomy group
than that in the control group (p 5 0.008) (Table 1). On
POD2 there was complete recuperation of the immune
response in the pneumoperitoneum group, whilst the DTH
response in the laparotomy group was still weaker when
compared with the other two groups (p,0.02) (Table 1).
Discussion
Many experiments have been carried out to elucidate the
behaviour of malignant cells in patients undergoing laparo-
scopic surgery, but they have produced diverse results
[16–18]. The present study found greater tumour growth in
animals submitted to laparotomy, supporting other experi-
mental studies [18,19] that have also found a better tumour
behaviour after laparoscopy than after laparotomy. The
cause of this difference in tumour growth remains
unknown. In contrast to other studies [19], we could not
demonstrate differences in tumour cell proliferation among
the groups studied. It is possible that the differences in
tumour growth are not related to factors that stimulate
tumour cell proliferation but rather to factors that repress
tumour growth, like the immune system.
To evaluate this hypothesis we used a DTH skin test,
which is a reliable method for the measurement of cellular
immune function in both human and animal studies
[24–26]. Several authors have shown a reversible decrease
in DTH skin reactions after operative procedures, which
confirms a decrease in cellular immune reaction as a result
of the operation [24–26]. The application of this method in
clinical settings has demonstrated a relationship between
postoperative morbidity and cancer behaviour, with low
DTH responses [25–27]. In the current study, cellular
immune response was evaluated in three groups of rats
(anaesthetic alone as control, pneumoperitoneum and
laparotomy). The results were like others reported in the
literature [5–7,24], in which immune function was better
preserved after CO
2
pneumoperitoneum than after laparo-
tomy. The Walker carcinosarcoma used in this experiment
is immunogenic [20,21]. As there was a great number of
lymphocytes infiltrating the tumours [22], the difference
observed in cellular immune function, in association with
other immune factors like natural killer cell activity and
monocyte-mediated cytotoxicity [7,8], might be responsible
for the differences in tumour growth.
In conclusion, animals submitted to laparotomy suffered
a greater tumour growth than those submitted to CO
2
pneumoperitoneum, possibly because of a stronger depres-
sion of the cellular immune response. Further studies to
assess the immune response in the tumoral tissue are now in
progress in our laboratory. Despite these encouraging results
and some favourable clinical reports [7,11,12], we believe
that laparoscopic operations for malignant diseases should
continue to be performed within the framework of ran-
domised clinical trials.
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Table 1. Immune response to KLH antigen on the first and
second POD (DTH skin reaction)
Inflammatory wheal (mm2)
Group First POD Second POD
Control 106 6 72.29 128.18 6 69.0 
Pneumoperitoneum 79.75 6 36.83 126.93 6 54.64 
Laparotomy *33.33 6 31.71 #61.32 6 47.22 
DTH 5 delayed-type hypersensitivity; POD 5 postoperative day; KLH 5
keyhole limpet haemocyanin.
*p,0.05 versus control, #p,0.05 versus control and
pneumoperitoneum.
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Figure 2. Individual and mean tumour weights on the seventh postoperative
day by groups: u 5 control; n 5 pneumoperitoneum; s 5 laparotomy.
*p,0.05 versus control and #p,0.05 versus pneumoperitoneum.
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